Vaxcyte
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -4,989 | ||
EBITDA | -209,766 | -161,584 | -175,919 |
EBIT | -212,830 | -166,573 | -180,793 |
Net Income | -212,830 | -166,573 | -140,718 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -155,351 | -101,650 | -193,025 |
Cash | 281,080 | 306,744 | 346,850 |
Basic Shares | 136,196 | 136,033 | 135,691 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -15,845 | -75,000 | -9,196 |
EBITDA | -448,082 | -392,095 | -214,030 |
EBIT | -463,927 | -402,266 | -223,483 |
Net Income | -463,927 | -402,266 | -223,485 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -475,054 | -364,667 | -176,438 |
Cash | 387,878 | 397,451 | 834,657 |
Basic Shares | 121,997 | 97,157 | 64,877 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.80 |
2025-09-30 | -$1.56 |
2025-06-30 | -$1.22 |
2025-03-31 | -$1.04 |
